DUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process

DUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process

Source: Department of Justice. This site is made available by China PR Agency – Professional Chinese Press Release Distribution service, Great China and Asia PR service provider. 【专业中文新闻稿发布，大中华地区及亚洲网络公关服务商】。